The article reports that high-dose flu vaccines, typically administered to those aged 65 and older, may also be more effective for adults aged 50 to 64, as observational data from over 1.6 million people suggests a 15 percent reduction in flu cases with a recombinant va...
The nasal spray flu vaccine for adults may cause: Cough Headache, muscle aches Runny nose, nasal congestion Sore throat Although it's rare, someone may have asevere allergic reactionto an ingredient in the vaccine. Most of the time, such reactions occur within a few minutes to a few hours...
Paquita Bonillo, 84 years old, receives the fourth dose of Covid-19 and flu vaccine in the garden of the Feixa Llarga nursing home on September 26, 2022 in Barcelona, Spain. Zowy Voeten | Getty Images The flu vaccine has been 68% effective at preventing hospitalizations in children bu...
Results from the 2023-2024 U.S. flu season show that in adults vaccine effectiveness against hospitalization ranged from 41% to 44%. Specifically for children and teens less than 18 years, the flu vaccine was 71% effective for preventing symptomatic influenza A illness. All vaccines in the 202...
Compared with standard-dose influenza vaccines, the high-dose vaccine is more effective in preventing influenza- or pneumonia-associated hospitalizations, cardiorespiratory hospitalizations, and all-cause hospitalizations among adults aged 65 and older...
Spraying flu vaccine into the noses of babies and preschoolers offers significantly more protection than shots, says one of the largest comparisons of flu inoculations ever performed.
(HealthDay)—HIV-infected adults achieve higher rates of seroprotection when immunized with a high-dose of the influenza trivalent vaccine compared to the standard dose, according to a study published in the Jan. 1 issue of the Annals of Internal Medicin
High-Dose Flu Vaccine Leads to Less Cardio-Respiratory Events in StudyDa Hee HanPharmD
A majority of young adults with cardiovascular disease are not receiving the annual influenza vaccine despite their heightened risk of secondary infections. A majority of young adults with cardiovascular disease (CVD) are not receiving the annual influenza (flu) vaccine despite their heightene...
*Preferentially recommended by ACIP for adults 65+ over non-adjuvanted, standard-dose influenza vaccines. Choose FLUAD for your eligible patients 65+ years16 Covered by Medicare Part B and by most Medicare Advantage Plans with no copay*